Total neoadjuvant treatment with short-course radiotherapy followed by sintilimab plus capecitabine–oxaliplatin versus short-course radiotherapy followed by capecitabine–oxaliplatin in patients with locally advanced rectal cancer (SPRING-01): a single-centre, open-label, phase 2, randomised controlled trial
Feng Tian(Sun Yat-sen University), Changqing Jing(Shandong Provincial Hospital), Hao Chen(Nanfang Hospital), Yuezhi Chen(Shandong Provincial Hospital), Liang Shang(Shandong Provincial Hospital), Haiyan Jing(Shandong Provincial Hospital), Renxiang Feng(Tengzhou Central People's Hospital), Hongqing Zhuo(Shandong Provincial Hospital), Jinshen Wang(Shandong Provincial Hospital), Yuanzi Yu(Shandong University), Jun Li(Jiangsu Province Hospital), Yubo Liu(Shandong Provincial Hospital), Leping Li(Shandong Provincial Hospital), Yulong Shi(Shandong Provincial Hospital), Xiaoqiao Zhang(Shandong Provincial Hospital), Dan Sha(Shandong Provincial Hospital), Hongjun Liu(Shandong Provincial Hospital), Cong Sun(Royal Children's Hospital), Guodong Lian(Shandong Provincial Hospital), Honghai Dai(Shandong Provincial Hospital), Zhe Yang(Shandong University)
Cited by 34
Related Papers
Childhood Adiposity, Adult Adiposity, and Cardiovascular Risk Factors
|New England Journal of Medicine|2011|1.6k
Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs
|Nature Biotechnology|2019|286